Who was Barbara Mitchell?
  1. new drug regulations
  2. new drug regulations

new drug regulations

Mai 30, 2023 4:30AM

Canadians wait much longer for drugs than Americans and Europeans

Dr. Nigel Rawson, Bacchus Barua
Printer-friendly version
Canadians wait much longer for drugs than Americans and Europeans

Government policies make Canada’s pharmaceutical environment less attractive to drug companies.

Étiquettes:
waiting for medical treatment, access to new drugs, new medicine, new drug approval, new drug regulations
Août 3, 2021 1:11PM

New review rules—the impact on drug access in Canada
Dr. Nigel Rawson
Printer-friendly version
New review rules—the impact on drug access in Canada

In 2017, the federal government introduced new regulations for the drug review board.

Étiquettes:
drug approval, access to medicines, new drug regulations, drug approval process
Juillet 29, 2021 12:02PM

Proposed ‘drug price’ changes threaten access for Canadian patients

Kristina M.L. Acri, née Lybecker
Printer-friendly version
Proposed ‘drug price’ changes threaten access for Canadian patients

Advanced clinical trials in Canada, which were consistent between 2015 and 2019, decreased by 26 per cent in 2020.

Étiquettes:
pmprb, canadian drug prices, drug costs, new drug regulations, patented drugs
Juillet 28, 2021 11:39AM

Delayed drug approvals in Canada—here’s why
Dr. Nigel Rawson
Printer-friendly version
Delayed drug approvals in Canada—here’s why

New drugs are approved later in Canada than in the United States and European Union.

Étiquettes:
drug approval delays, drug approval process, new drug approval, new drug regulations, access to new drugs
Mai 13, 2021 1:00AM

Timely Access to New Pharmaceuticals in Canada, the United States, and the European Union
Bacchus Barua, Will Westcott, Van Nghiem Vo
Printer-friendly version
Timely Access to New Pharmaceuticals in Canada, the United States, and the European Union
Étiquettes:
access to medicines, access to new drugs, access to new medicine, new prescription drugs, new drug approval, new drug regulations, new drugs, pharmaceutical
Août 14, 2019 7:40PM

Ottawa’s changes to drug-pricing will deny some Canadians potentially lifesaving drugs
Dr. Nigel Rawson
Printer-friendly version
Ottawa’s changes to drug-pricing will deny some Canadians potentially lifesaving drugs

Forcing manufacturers of high-cost drugs to reduce their prices by up to 80 per cent is unsustainable.

Étiquettes:
pharmacare, canadian drug prices, new drug regulations, pmprb, patented drugs
Février 21, 2019 10:03AM

Trudeau government's drug-pricing plan may limit access to new life-improving medicines
Bacchus Barua, Steven Globerman
Printer-friendly version
Trudeau government's drug-pricing plan may limit access to new life-improving medicines

Developing and testing new drugs costs a lot of money.

Étiquettes:
drug price controls, access to new drugs, access to new medicine, new prescription drugs, new drug regulations
Août 28, 2018 1:00AM

Regulatory, Reimbursement, and Pricing Barriers to Accessing Drugs for Rare Disorders in Canada
Dr. Nigel Rawson
Printer-friendly version
Regulatory, Reimbursement, and Pricing Barriers to Accessing Drugs for Rare Disorders in Canada
Étiquettes:
drug patent laws, patented prescription drugs, access to new drugs, new drug regulations, pharmaceutical patents
Juin 19, 2014 6:00AM

The Benefits of Incremental Innovation
Steven Globerman, Kristina M.L. Acri, née Lybecker
Printer-friendly version
Étiquettes:
incremental innovation, technological innovation, scientific innovation, new drug regulations, drug approval process, new drug approval, aids treatment, cancer-fighting drugs, anti-malarial drugs
Juin 26, 2007 2:00AM

Risk, Progressive Licensing and the Health Benefits Lost by Over-Regulating New Drugs
Brett J. Skinner
Printer-friendly version
Étiquettes:
prescription drugs, drug safety regulation, drug safety standards, new drug regulations, Progressive Licensing